Uji Klinik Multicenter Formula Jamu Hiperkolesterolemia Dibanding Simvastatin

Edisi

-

ISBN/ISSN

-

Deskripsi Fisik

419 LIT

Judul Seri

-

No. Panggil

419 LIT

Observasi klinis ramuan jamu untuk hiperkolesterlemia II

Edisi

-

ISBN/ISSN

-

Deskripsi Fisik

48 p

Judul Seri

-

No. Panggil

334 LIT

Study preklirik ramuan jamu untuk hiperkolesterolemia

Edisi

-

ISBN/ISSN

-

Deskripsi Fisik

43 p

Judul Seri

-

No. Panggil

324 LIT

Kadar Kolesterol Tinggi Dan Faktor-Faktor Yang Berpengaruh Terhadap Kadar Kol…

Background: Cholesterollevel in blood has become one of the risk factors of heart disease. One of the risk factors of heart disease is high cholesterol level. This article analyzes variables that injluence high cholesterol level in blood. Method: Data were obtained from national health research in 2007. Data consist of 21.178 respondents was cleaned up to become 4.566 cleaned data ready to be…

Sikap Orang Yang Berusia Madya (40-60 Tahun) Terhadap Konsumsi Bahan Makanan …

Middle age is age between 40-60 years old where it is a long period of human life. Middle age is risky age on degenerative disease, but also poses potential to keep healthy by changing life style. Hyper-cholesterol is common disease suffered by this age group, caused by wrong life style, such as consumption of food stuff with excessive hypercholesterol risk. This research aimed to identify …

Hidup Nyaman dengan Hiperkolesterol

Edisi

-

ISBN/ISSN

979-006-431-4

Deskripsi Fisik

106 p.; bibl, ilus.; 20 cm

Judul Seri

-

No. Panggil

WD 200.5 YUD 2012

FDA Menyetujui Colesevelam sebagai Anak-Anak Hiperkolesterolemia

Edisi

-

ISBN/ISSN

0125-913X

Deskripsi Fisik

1p.

Judul Seri

-

No. Panggil

Cermin Dunia Kedokteran:37(2)2010:121

Resuvastatin sebagai Terapi Pasien Pedatri dengan Hiperkolesterolemia Familial

Edisi

-

ISBN/ISSN

0125-913X

Deskripsi Fisik

-

Judul Seri

-

No. Panggil

Cermin Dunia Kedokteran:37(2):136

FDA Menyetujui Colesevelam sebagai Terapi Bagi Anak-Anak Hiperkolesterolemia

Edisi

-

ISBN/ISSN

0125-913X

Deskripsi Fisik

-

Judul Seri

-

No. Panggil

Cermin Dunia Kedokteran:37(2):121

Safety and Tolerability of Fluvastatin XL, in the Treatment of Hypercholester…

Fluvastatin XL 80 mg tablet has been marketed in Indonesia since Desember 2002. This post-marketing surveillance (PMS) was conducted between May 2004 and April 2005 involving 98 general physicians to observe the sofety and tolerability of fluvastatin XL 80 mg once daily at bedtime for 8 weeks in the treatment of outpatiens with hypercholesterolemia. The afficacy of the drug inlowering LDL chole…